Pharmacology and Toxicology Department Highlights: November 2019

(November 1, 2019)

Presentations

Heidi Mansour, PhD, RPh

  • PhD Graduate Program Faculty Representative, AACP Pharmacy Virtual Fair for UA COP, Wednesday 9/25/19
  • Invited Presenter, UA COP Discover Pharmacy Open House, Presentation Title “PharmD/PhD Dual-Degree Program), Friday 10/25/19

Kudos

Heidi Mansour, PhD, RPh

  • No. 62/897,106 patent for invention #UA19-252 “Stable Long-Term Infusable Formulations and Methods” Inventors: Ronald Shebuski, PhD., Heidi M. Mansour, PhD, and Priya Muralidharan, PhD
  • New Exclusive License: UA with CyleruS, INC. for invention No. 62/897,106 patent  (Articles on Research Outreach and SciTech Europa)

Jun Wang, PhD

  • Dr. Wang was invited to join the editorial board of Frontiers in Microbiology – Virology Section
  • Dr. Wang was invited to join the editorial board of Scientific Reports
  • Dr. Wang was invited to give a talk entitled “Medicinal Chemistry and Pharmacology of Antivirals” at the School of Molecular Sciences, Arizona State University
  • Dr. Wang was invited to give a talk entitled “Medicinal Chemistry and Pharmacology of Antivirals” at the Department of Chemistry, University of Texas, El Paso

Research

Jun Wang, PhD

It is flu season. Dr. Wang’s research in developing antivirals targeting drug-resistant influenza viruses has been highlighted by Nature and Scientific American. Their team is currently exploring different strategies in developing influenza antivirals with broad-spectrum antiviral activity and a high genetic barrier to drug resistance. They have made promising progress in targeting the viral M2-S31N proton channel, the viral polymerase PA-PB1 interactions, and the viral hemagglutinin. They are currently working on testing the in vivo efficacy of the lead compounds in mouse model studies.  These molecules can be used either alone or in combination to prevent and treat both drug-sensitive and –resistant influenza virus infections.